Stem cell protein BMI‐1 is an independent marker for poor prognosis in oligodendroglial tumours

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuropathology and Applied Neurobiology

• Publication date

  2008-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2990.2008.00949.xPMID 18346113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• breast cancer cells

  2009cited by this paper
• Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.

  2007cited by this paper
• Cancer Stem Cells

  2007cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances.

  2006cited by this paper
• Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death

  2006cited by this paper
• Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.

  2006cited by this paper
• Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells.

  2006cited by this paper
• Cancer stem cells.

  2006cited by this paper
• Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

  2005cited by this paper
• Genetic pathways to glioblastomas

  2005cited by this paper
• Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.

  2005cited by this paper
• Bmi1 Loss Produces an Increase in Astroglial Cells and a Decrease in Neural Stem Cell Population and Proliferation

  2005cited by this paper
• Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways.

  2005cited by this paper
• Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions.

  2005cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas

  2004cited by this paper
• Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.

  2004cited by this paper
• Prognostic Value of the Expression of Tumor Suppressor Genes p53, p21, p16 and pRb, and Ki-67 Labelling in High Grade Astrocytomas Treated with Radiotherapy

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

  2003cited by this paper
• Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells

  2003cited by this paper
• Cancerous stem cells can arise from pediatric brain tumors

  2003cited by this paper
• Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

  2002cited by this paper
• The INK4a/ARF network in tumour suppression

  2001cited by this paper
• Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

  2000cited by this paper
• Pathology and genetics of tumours of the nervous system.

  2000cited by this paper
• CDKN2/p16 Predicts Survival in Oligodendrogliomas: Comparison with Astrocytomas

  1999cited by this paper
• MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation.

  1999cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997cited by this paper

• Insights Into the Role of Bmi‐1 Deregulation in Promoting Stemness and Therapy Resistance in Glioblastoma: A Narrative Review

  2025cites this paper
• Lymphocyte to monocyte ratio predicts survival and is epigenetically linked to miR-222-3p and miR-26b-5p in diffuse large B cell lymphoma

  2023cites this paper
• Expression and therapeutic targeting of BMI1 in canine gliomas.

  2022cites this paper
• MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.

  2019cites this paper
• Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer

  2018cites this paper
• Prognostic value of O‐6‐methylguanine–DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis

  2018cites this paper
• Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma

  2017cites this paper
• 2-20-2012 Bmi-1 Absence Causes Premature Brain Degeneration

  2017cites this paper
• Stemness-related markers in cancer

  2017cites this paper
• Mechanisms regulating radiosensitivity of glioma stem cells.

  2017cites this paper
• Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets

  2016cites this paper
• BRAIN TUMOR STEM CELLS : PHENOTYPIC CHARACTERIZATION AND DIRECTED THERAPEUTIC

  2016cites this paper
• Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance

  2016cites this paper
• Bmi‐1 regulates the migration and invasion of glioma cells through p16

  2015cites this paper
• Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma

  2015cites this paper
• Cancer Stem Cells , Therapeutic Implications

  2015cites this paper
• Brain tumor stem cells: phenotypic characterization and directed therapeutic approaches

  2015cites this paper
• Bmi-1: At the crossroads of physiological and pathological biology

  2015cites this paper
• Radiation therapy for glioma stem cells.

  2015cites this paper
• miR‐200c/Bmi1 axis and epithelial–mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment

  2015cites this paper
• Identification and quantification of FXN antisense transcript 1 (FAST-1) in Friedreich ataxia

  2015cites this paper
• Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms

  2015cites this paper
• The role of polycomb repressive complexes in biliary tract cancer

  2015cites this paper
• The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells

  2015cites this paper
• CD133 and BMI1 expressions and its prognostic role in primary glioblastoma

  2015cites this paper
• Overexpression and lack of copy number variation in the BMI-1 gene in human glioma.

  2015cites this paper
• Downregulated miR-45 Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer

  2015cites this paper
• ShRNA targeting Bmi-1 sensitizes CD44⁺ nasopharyngeal cancer stem-like cells to radiotherapy.

  2014cites this paper
• Clinical value of CD 133 and nestin in patients with glioma : a population-based study

  2014cites this paper
• Original Article Clinical value of CD133 and nestin in patients with glioma: a population-based study

  2014cites this paper
• A novel NF-κB/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1

  2014cites this paper
• Analysis of Circadian Properties and Clock Regulation of Glioma and Breast Cancer Stem Cells

  2014cites this paper
• Set up of different strategies to selectively target Glioblastoma Cells

  2014cites this paper
• Bmi-1 induces radioresistance by suppressing senescence in human U87 glioma cells

  2014cites this paper
• Clinical value of CD133 and nestin in patients with glioma: a population-based study.

  2014cites this paper
• Brain tumor stem cells: Molecular characteristics and their impact on therapy.

  2014cites this paper
• [Glial brain tumor stem cells].

  2013cites this paper
• Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.

  2013cites this paper
• What is the clinical value of cancer stem cell markers in gliomas?

  2013cites this paper
• Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms

  2013cites this paper
• Role of B lymphoma Mo-MLV insertion region 1 in the oncogenic behavior of retinoblastomas

  2013cites this paper
• Glioma spheroids obtained via ultrasonic aspiration are viable and express stem cell markers: a new tissue resource for glioma research.

  2013cites this paper
• Tumor Dormancy in Breast Cancer

  2012cites this paper
• Bmi-1 Absence Causes Premature Brain Degeneration

  2012cites this paper
• Polycomb genes and cancer: time for clinical application?

  2012cites this paper
• Glioblastoma cancer stem cells: Basis for a functional hypothesis

  2012cites this paper
• Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences

  2012cites this paper
• Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma.

  2012cites this paper
• International Evaluation of Research and Doctoral Training at the University of Helsinki 2005-2010: RC-Specific Evaluation of PURE - Public Health and Epidemiology Research Community

  2012cites this paper
• Molecular pathology in adult high‐grade gliomas: from molecular diagnostics to target therapies

  2012cites this paper
• GFAP-Cre-Mediated Transgenic Activation of Bmi1 Results in Pituitary Tumors

  2012cites this paper
• Expressão de marcadores de células-tronco em carcinoma espontaneo de mama em cadelas e sua correlação com o grau de agressividade nos diferentes subtipos de tumores

  2012cites this paper
• Association of stem cell marker expression pattern and survival in human biliary tract cancer.

  2012cites this paper
• Tumor suppressive pathways in the control of neurogenesis

  2012cites this paper
• Neural stem cells and their role in the pathology and classification of central nervous system tumors.

  2011cites this paper
• Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme

  2011cites this paper
• Three-Dimensional In Vitro Models in Glioma Research - Focus on Spheroids

  2011influential citation
• Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer

  2011cites this paper
• Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases—elevated Bmi-1 expression in late breast cancer relapses

  2011cites this paper
• Targeting glioma stem cells: enough to terminate gliomagenesis?

  2011cites this paper
• Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma—do they have a role?

  2011cites this paper
• Investigating the role of Bmi-1 in liver growth and function

  2011cites this paper
• Neural Stem Cells and their Role in the Pathology and Classification of Central Nervous System Tumors Nöral Kök Hücreler ve Santral Sinir Sistemi Tümörlerinin Patolojisinde ve Siniflandirmasinda Rolleri

  2011cites this paper
• Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue

  2010cites this paper
• Human Cancer Biology Ewing Tumors That Do Not Overexpress BMI-1 Are a Distinct Molecular Subclass with Variant Biology : A Report from the Children ' s Oncology Group

  2010cites this paper
• Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation.

  2010cites this paper
• Ewing Tumors That Do Not Overexpress BMI-1 Are a Distinct Molecular Subclass with Variant Biology: A Report from the Children's Oncology Group

  2010cites this paper
• Can BMI-1 be a biomarker of poor prognosis?

  2010cites this paper
• Establishment of Prognostic Models for Astrocytic and Oligodendroglial Brain Tumors with Standardized Quantification of Marker Gene Expression and Clinical Variables

  2010cites this paper
• Anti-proliferation effect of BMI-1 in U937 cells with siRNA.

  2010cites this paper
• Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma

  2010cites this paper
• Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells

  2010cites this paper
• Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1.

  2010cites this paper
• Adult neural stem cells and their role in brain pathology

  2009cites this paper
• Brain Tumor Stem Cell Markers

  2009cites this paper
• Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer.

  2009cites this paper
• Bmi-1, stem cells and cancer.

  2009cites this paper
• The Role of Polycomb Group Gene BMI-1 in the Development of Prostate Cancer

  2009cites this paper
• Copy number alterations of the polycomb gene BMI1 in gliomas

  2008cites this paper
• Author Index to Volume 34

  2008cites this paper